183 related articles for article (PubMed ID: 8763423)
1. Keratinocytes express dipeptidyl-peptidase IV (CD26) in benign and malignant skin diseases.
Novelli M; Savoia P; Fierro MT; Verrone A; Quaglino P; Bernengo MG
Br J Dermatol; 1996 Jun; 134(6):1052-6. PubMed ID: 8763423
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous lymphocyte antigen expression in benign and neoplastic cutaneous B- and T-cell lymphoid infiltrates.
Magro CM; Dyrsen ME
J Cutan Pathol; 2008 Nov; 35(11):1040-9. PubMed ID: 18681860
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors 2, 4 and 9 expression in cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome).
Jarrousse V; Quereux G; Marques-Briand S; Knol AC; Khammari A; Dreno B
Eur J Dermatol; 2006; 16(6):636-41. PubMed ID: 17229603
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-7 receptor expression in cutaneous T-cell lymphomas.
Bagot M; Charue D; Boulland ML; Gaulard P; Revuz J; Schmitt C; Wechsler J
Br J Dermatol; 1996 Oct; 135(4):572-5. PubMed ID: 8915148
[TBL] [Abstract][Full Text] [Related]
5. Expression of epithelial antigens Exo-1 and EPM-1 in human epidermal keratinocyte maturation and benign and malignant neoplasia.
Klingel R; Boukamp P; Moll R; Tilgen W; Fusenig NE; Meyer zum Büschenfelde KH; Dippold WG
Cancer Res; 1990 Dec; 50(23):7668-76. PubMed ID: 2253212
[TBL] [Abstract][Full Text] [Related]
6. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
[TBL] [Abstract][Full Text] [Related]
7. CD26/dipeptidyl-peptidase IV in psoriatic skin: upregulation and topographical changes.
van Lingen RG; van de Kerkhof PC; Seyger MM; de Jong EM; van Rens DW; Poll MK; Zeeuwen PL; van Erp PE
Br J Dermatol; 2008 Jun; 158(6):1264-72. PubMed ID: 18384439
[TBL] [Abstract][Full Text] [Related]
8. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
[TBL] [Abstract][Full Text] [Related]
9. Absence of CD26 expression on skin-homing CLA+ CD4+ T lymphocytes in peripheral blood is a highly sensitive marker for early diagnosis and therapeutic monitoring of patients with Sézary syndrome.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Steitz J; Roszkiewicz J; Bieber T; Tüting T
Clin Exp Dermatol; 2005 Nov; 30(6):702-6. PubMed ID: 16197392
[TBL] [Abstract][Full Text] [Related]
10. [Skin associated lympphoid tisues (SALT). Its normal and pathological function].
Robledo Aguilar A
An R Acad Nac Med (Madr); 2006; 123(2):367-77; discussion 377-9. PubMed ID: 17310641
[TBL] [Abstract][Full Text] [Related]
11. MY7 monoclonal antibody for diagnosis of cutaneous T-cell lymphoma.
Dreno B; Bureau B; Stalder JF; Litoux P
Arch Dermatol; 1990 Nov; 126(11):1454-6. PubMed ID: 2146925
[TBL] [Abstract][Full Text] [Related]
12. [In situ - demonstration of helper-T-lymphocytes in cutaneous malignant lymphomas by diaminopeptidase IV (DAP IV)].
Sterry W; Steigleder GK; Goos M; Meisterernst E
Z Hautkr; 1982 Apr; 57(8):567-76. PubMed ID: 6124066
[TBL] [Abstract][Full Text] [Related]
13. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
López-Lerma I; Estrach MT
J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
[TBL] [Abstract][Full Text] [Related]
14. Keratinocyte and epidermal leukocyte expression of CD36 (OKM5) in benign and malignant skin diseases.
Lisby S; Ralfkiaer E; Hansen ER; Vejlsgaard GL
Acta Derm Venereol; 1990; 70(1):18-22. PubMed ID: 1689091
[TBL] [Abstract][Full Text] [Related]
15. Expression of the CD1a molecule in B- and T-lymphoproliferative skin conditions.
Pigozzi B; Bordignon M; Belloni Fortina A; Michelotto G; Alaibac M
Oncol Rep; 2006 Feb; 15(2):347-51. PubMed ID: 16391853
[TBL] [Abstract][Full Text] [Related]
16. Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7.
Sokolowska-Wojdylo M; Wenzel J; Gaffal E; Lenz J; Speuser P; Erdmann S; Abuzahra F; Bowman E; Roszkiewicz J; Bieber T; Tüting T
Br J Dermatol; 2005 Feb; 152(2):258-64. PubMed ID: 15727636
[TBL] [Abstract][Full Text] [Related]
17. Killer cell immunoglobulin-like receptor expression delineates in situ Sézary syndrome lymphocytes.
Wechsler J; Bagot M; Nikolova M; Parolini S; Martin-Garcia N; Boumsell L; Moretta A; Bensussan A
J Pathol; 2003 Jan; 199(1):77-83. PubMed ID: 12474229
[TBL] [Abstract][Full Text] [Related]
18. Carcinoembryonic antigen and related antigens expressed on keratinocytes in inflammatory dermatoses.
Egawa K; Honda Y; Kuroki M; Inaba Y; Ono T
Br J Dermatol; 1996 Mar; 134(3):451-9. PubMed ID: 8731668
[TBL] [Abstract][Full Text] [Related]
19. CD7 expression in reactive and malignant human skin T-lymphocytes.
Alaibac M; Pigozzi B; Belloni-Fortina A; Michelotto A; Saponeri A; Peserico A
Anticancer Res; 2003; 23(3B):2707-10. PubMed ID: 12894562
[TBL] [Abstract][Full Text] [Related]
20. Beta-2-microglobulin and HLA-DR(Ia)-antigens in normal and pathological skin.
Tjernlund U
Acta Derm Venereol Suppl (Stockh); 1981; 94():1-40. PubMed ID: 6169248
[No Abstract] [Full Text] [Related]
[Next] [New Search]
